PENTAIR plc

PNR

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Eventide Asset Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Eventide Asset ManagementNEWFeb 13, 2026

Shares: 326,280Value: $34.0M

**Signal Note: Eventide Initiates $34M PNR Position** This signal appears misaligned with Eventide's biotech-focused mandate—Pentair is a diversified water and industrial equipment manufacturer with no therapeutic pipeline. The position may reflect either: (1) a portfolio rebalancing into non-biotech holdings, (2) exposure to water purification/healthcare infrastructure trends, or (3) data error. No obvious biotech catalyst or drug development driver supports this allocation for a values-focused biotech specialist.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

CPRT1 fund DECK1 fund LITE1 fund NTAP1 fund GPI1 fund IMMX1 fund PI1 fund UNP1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: